RBD-1119

N/A

Report date: 2025/07/01 20:00:14
NME

Base Information

Drug NameRBD-1119
Drug Alias NameRBD-1119RBD1119
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAsialoglycoprotein receptor modulators
TargetsAsialoglycoprotein receptor
Therapy Area/IndicationsEmbolism and Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Ribo Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Ribo Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsEmbolism and Thrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A